Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
JAZZ | Jazz Pharmaceuticals plc | Chairman & CEO, Director | $50.5M | Mar 5, 2024 | ||
SLRN | ACELYRIN, Inc. | Director | Jun 7, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|